Department of Fetal Medicine 4002, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Acta Obstet Gynecol Scand. 2011 Jul;90(7):728-36. doi: 10.1111/j.1600-0412.2011.01156.x. Epub 2011 May 26.
To determine the impact which introduction of the 11-14 week scan has had on the gestational age at which fetal malformations are detected by ultrasound in an unselected population of pregnant women.
Retrospective study.
University hospital, Copenhagen, Denmark, covering the period 1 January 2003 to 30 June 2007.
All pregnant women who chose a nuchal translucency scan at 11-14 weeks for Down syndrome risk estimate, and a scan at 18-20 weeks to screen for fetal malformations.
Review of cases detected ante- and postnatally.
Detection rates at 11-14 weeks relative to all malformations in the population.
A total of 216 anomalies were detected in 200 fetuses among the 9 324 fetuses included, while 70 anomalies were diagnosed in 59 infants postnatally. The prevalence of fetuses with anomalies was 2.8% (259 of 9 324). After excluding cases of pyelectasis (127), which may be considered physiological and transitory changes, the prevalence of malformed fetuses was 1.4% (132 of 9 324). Of the malformations detected antenatally, 25.8% were detected before week 15 and 59.6% in weeks 16-22. The remaining 14.6% of malformations were discovered after week 22. Among the lethal malformations, 50% were diagnosed before week 15.
Although the purpose of the first trimester scan is to screen for Down syndrome and not for malformations, the introduction of the 11-14 week scan has resulted in the detection of approximately 26% of fetal malformations.
确定在未选择的孕妇人群中,11-14 周超声扫描的引入对胎儿畸形的检测孕周有何影响。
回顾性研究。
丹麦哥本哈根大学医院,涵盖 2003 年 1 月 1 日至 2007 年 6 月 30 日期间。
所有选择在 11-14 周进行颈项透明层扫描以评估唐氏综合征风险,并在 18-20 周进行超声扫描以筛查胎儿畸形的孕妇。
回顾性病例分析。
11-14 周时检出率与人群中所有畸形的关系。
在纳入的 9324 例胎儿中,共在 200 例胎儿中发现了 216 例畸形,70 例畸形在新生儿期确诊。胎儿畸形的发生率为 2.8%(259/9324)。排除可能为生理性和一过性改变的肾积水(127 例)后,胎儿畸形的发生率为 1.4%(132/9324)。在产前检出的畸形中,25.8%在 15 周前检出,59.6%在 16-22 周检出。其余 14.6%的畸形在 22 周后发现。在致死性畸形中,50%在 15 周前诊断。
虽然早孕期扫描的目的是筛查唐氏综合征而非畸形,但 11-14 周扫描的引入导致约 26%的胎儿畸形被检出。